Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-590-1 | CAS number: 15541-60-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
MPP has low acute oral (LD50>2000 mg/kg bw) and dermal toxicity (LD50>2000 mg/kg bw) in rats. There are no data available on the acute inhalational toxicity of the notified polymer.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 December 2003 to 5 January 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducted in accordance with an internationally recognised method
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: reputable supplier of laboratory animals
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 196-206g
- Fasting period: overnight (prior to dosing), 3-4 hours after dosing
- Housing: in groups of three in suspended solid-floor polypropylene cages furnished with wood flakes
- Diet: certified rat and mouse diet, ad libitum.
- Water: mains drinking water, ad libitum:
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 30 to 70%
- Air changes (per hr): at least 15 per hour
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES: From: 8 December 2003 To: 10 December 2003 - Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/ml
- Amount of vehicle (if gavage): 10 ml
- Justification for choice of vehicle: produced suspension suitable for dosing
MAXIMUM DOSE VOLUME APPLIED: 10 ml
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: consideration of all available toxicity information 2000 mg/kg was chosen as the starting dose
Determination by analysis of the concentration, homogeneity and stability of the test material preparations was not appropriate because it was not specified in the Study Plan and is not a requirement of the Test Guideline. - Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 6
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: the animals were observed for deaths or overt signs of toxicity 0.5, 1, 2 and 4 hours after dosing
and subsequently once daily for fourteen days. Individual bodyweights were recorded prior to dosing and seven and fourteen days after
treatment.
- Necropsy of survivors performed: yes
- Other examinations performed: no - Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths.
- Clinical signs:
- other: There were no signs of systemic toxicity.
- Gross pathology:
- No abnormalities were noted at necropsy.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral median lethal dose (LD50) of the test material in the female Sprague-Dawley CD strain rat was estimated as being greater than 2500 mg/kg bodyweight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- A well conducted study performed under GLP in accordance with a recognised guideline.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 September to 9 November 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducted in accordance with an internationally recognised method
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1200 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries, Test Data for Registration of Agricultural Chemicals, Acute dermal toxicity (2-1-2), 12 Nousan No. 8147, Agricultural Production Bureau, November 24, 2000.
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: CD (Crl:CD ‘SD’)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: reputable laboratory animal supplier
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 228 to 370 g
- Fasting period before study:
- Housing: solid bottomed polycarbonate cages with stainless steel mesh lid. Housed individually for Day1-10 then returned to groups of five animals of the same sex.
- Diet: standard rodent diet, ad libitum
- Water: potable water taken from public supply, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23
- Humidity (%): 40-70
- Air changes (per hr): none, continuous supply
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES: From: 16 September 2010 To: 6 October 2010 - Type of coverage:
- semiocclusive
- Vehicle:
- corn oil
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorso-lumbar region
- % coverage: 10
- Type of wrap if used: waterproof dressing
REMOVAL OF TEST SUBSTANCE
- Washing (if done): at end of exposure period the treated area of skin was washed with a mild detergent and water (30-40°C) then acetone (to remove residual test substance), followed by warm water. The treated area was then blotted dry with absorbent paper.
- Time after start of exposure: 24 hours
TEST MATERIAL
The test substance was formulated at a maximum practical concentration of 71.4% w/v in the vehicle and administered at a volume of 2.8 mL/kg bodyweight. The test substance formulation was prepared on the day of dosing - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed:
Mortality: cages of rats were checked at least twice daily for any mortalities.
Clinical observations: animals were observed soon after dosing and at frequent intervals for the remainder of Day 1. On subsequent days, animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity, where appropriate, of the clinical signs and the time were recorded at each observation. All animals were observed for 14 days after dosing.
Dermal reactions: local dermal irritation at the treatment site was assessed daily
Bodyweight:
The weight of each rat was recorded on Days 1 (prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean bodyweights were calculated. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths to treatment in any animal.
- Clinical signs:
- other: There was no systemic response to treatment in any animal.
- Gross pathology:
- No abnormalities were noted in any animal at the macroscopic examination at study termination on Day 15.
- Other findings:
- Very slight erythema was seen in one male on Day 2, resolving by Day 3 and in one female from Day 3, resolving by Day 10.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute median lethal dermal dose (LD50) to rats of MPP was demonstrated to be greater than 2000 mg/kg bodyweight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Quality of whole database:
- A well conducted study performed under GLP in accordance with a recognised guideline.
Additional information
In an acute oral toxicity study conducted on rats at a limit dose of 2500 mg/kg, there were no deaths and no signs of systemic toxicity. All animals showed expected bodyweight over the study period and no abnormalities were noted at necrospy. These data indicate that MPP is practically non-toxic at the level tested with an LD50 greater than 2500 mg/kg body weight.
No study for acute toxicity by inhalation is available. Testing is considered to be scientifically unjustified taking into account the physicochemical properties of the substance which make exposure by inhalation unlikely.
In an acute dermal toxicity study conducted on rats at a limit dose of 2000 mg/kg there were no deaths, no systemic response in any animal. No abnormalities were noted at in any animal at macroscopic examination. These data indicate that MPP is practically non-toxic
at the level tested with an LD50 of greater than 2000 mg/kg body weight.
Justification for selection of acute toxicity – oral endpoint
One available study.
Justification for selection of acute toxicity – inhalation endpoint
According to Reach Annex VIII end point 8.5.2, the study does not need to be conducted if inhalation is unlikely taking into account the substance particles of an inhalable size. The granulometry study shows that <10% by mass of MPP particles are <10µm, therefore an acute inhalation study is not warranted. Furthermore, approximately 24% by mass of particles are > 100 µm, this is accepted as a non-respirable fraction.
Justification for selection of acute toxicity – dermal endpoint
One available study.
Justification for classification or non-classification
Acute toxicity oral
LD50 for single exposure to rats is greater than the category 4 classification band of 300 -2000 mg/kg, as prescribed in table 3.1.1 of CLP Regulation No (EC) 1272/2008. MPP is therefore not classified.
Acute toxicity dermal
LD50 for single exposure to rats is greater than the category 4 classification band of 1000 -2000 mg/kg, as prescribed in table 3.1.1 of CLP Regulation No (EC) 1272/2008. MPP is therefore not classified.
Acute toxicity inhalation
No data available - classification not possible
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.